. 2020 Sep 10;9(10):963–970. doi: 10.1530/EC-20-0419
This work is licensed under a Table 2.
Characteristics of the subjects in the study.
| NFI (n = 82) | ACS (n = 83) | |
|---|---|---|
| Women, n (%) | 48 (56.1) | 58 (69.9) |
| Age, median, years (range) | 68.5 (33–82) | 65 (29–86) |
| BMI, median, kg/m2 (range) | 28.6 (18.3–42.6) | 26.1 (16.4–45.2) |
| Hypertension, n (%)a | 42 (50.9) | 54 (64.8) |
| Diabetes type II, n (%)a | 7 (8.5) | 14 (16.7) |
| HbA1c, median, % (range) | 5.7 (5–9) | 5.8 (5–9) |
| Treatment for dyslipidemia, n (%)a | 16 (19.5) | 18 (21.7) |
| Osteoporosis, n (%)a | 7 (8.5) | 15 (18.1) |
| Creatinine, median, µmol/L (range) | 75 (40–138) | 72 (39–971) |
| Smokers, n (%)a | 31 (37.8) | 30 (36.1) |
| Unilateral AI, n (%) | 66 (81.0) | 66 (79.2) |
| Size of unilateral AI, median, mm (range) | 22 (9–70) | 24 (10–51) |
| Bilateral AI, n (%) | 16 (19.0) | 17 (20.8) |
| Size of largest AI if bilateral, median, mm (range) | 28 (13–45) | 33 (21–42) |
Categorical data are given as number and percent, continuous data as median and range. In the case of bilateral AI, only the largest of the two lesions was included when calculating median size and range.
aSignificant difference between the NFI and the ACS group. P < 0.05.